Delivery Order SPE2DB22D1202-SPE2DB24FUWM7
Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA). The $11,323.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 25, 2024 with a completion date of July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,728.26, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is January 7, 2025. This award is not associated with a set-aside designation. AmerisourceBergen...
- This federal contract award, SPE2DB22D3501|SPE2DB24FTF43, is for the supply of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA). The $2,274.85 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 19, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $13,231.31, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract with a firm fixed price, issued by the Defense Logistics Agency (DLA) for the provision of GEMTESA 75 MG TABLET 90S, a medical supply product. The contract has an ultimate completion date of May 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a Firm Fixed Price basis with a ceiling value of $1,704.02. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 18, 2024 for a ceiling value of $9,949.40. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of October 21, 2024. This award is not...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,671.67 and a completion date of July 8, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and was awarded on July 5, 2024. No set-aside designation was used for this...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $51,951.84 firm fixed price contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of June 4, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves...
- This federal contract award is a Delivery Order valued at $16,819.82 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a prescription medication, with a performance period extending until July 9, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award is for delivery orders of the pharmaceutical product "GEMTESA 75 MG TABLET 90S" to the Defense Logistics Agency (DLA). The contract, which does not have a set-aside designation, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $17,362.54 and a completion date of March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...